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INTERLEUKIN 7 AS INTERLEUKIN 9 DRIVES 
PHYTHOHEMAGGLUTININ-ACTIV ATED T CELLS 
THROUGH SEVERAL CELL CYCLES; NO 
SYNERGISM BETWEEN INTERLEUKIN 7, 
INTERLEUKIN 9 AND INTERLEUKIN 4 
Thomas Lehrnbecher, * Martin Poot, t Karin Orscheschek,* Walter Se bald,§ 
Alfred C. Feiler ,:j: Hartmut Merz:j: 
The effects of the interlenkins IL-7 and IL-9 on cell cycle progression were investigated by 
conventional [3H]thymidine incorporation and by the bivariate BrdU/Hoechst technique. 
8oth IL· 7 and IL-9 drive phytohemagglutinin-activated T cells through more than one cell 
cycle, but IL-7 wasmorepotent on cell cycle progression than IL-9. Neither synergistic nor 
inhibitory effects were seen between various combinations of the lymphokines IL-7, IL-9 and 
IL-4 compared to each lymphokine alone. When T cells are activated with phytohemaggluti-
nin for 3 days, all or most IL-4 responsive cells respond to IL-7 as weil, whereas only a part of 
IL-7 responders are IL-4 responders. In contrast, when T cells are activated with phytohem-
agglutinin for 7 days, the quantitative data of the cell cycle distribution soggest that the 
population of IL-7 responders is at least an overlapping, if not a real subset of the population 
of the IL-4 responders. 
T lymphocytes are regulated at multiple Ievels by 
a complex network of haematopoietic cells and cyto-
kines. It has become clear that interleukin 2 (IL-2) is 
not the only factor controlling T cell growth, but 
several cytokines including interleukin 4 (IL-4), 
tumour necrosis factor, granulocyte/macrophage 
colony-stimulating factor, interleukin 1 (IL-1) and 
interleukin 6 (IL-6) are also involved. 1- 5 In recent 
reports it has been shown that IL-7, initially described 
as a haematopoietic growth factor for early B lineage 
cells, 6 can act on T cell growth as well. 7 Interleukin 9 
(IL-9), also known as T cell growth f~ctor P40 in the 
mouse system, was originally described as a mouse T 
cell growth factor for certain T celllines. 8• 9 However, 
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it was seen that IL-9 also mediates activities on eryth-
roid progenitors and fetal thymocytes. 10• 11 
In most reports data about T cell proliferation are 
obtained only by measurements of the [3H]thymidine 
incorporation,I2- 14 but little is known about cell kin-
etics ofT cells stimulated with different lymphokines. 
We have shown that IL-2 as weil as IL-4 can drive 
PHA-activated T cells through more than one cell 
cycle. Neither synergistic nor inhibitory effect on T 
cell proliferation was seen for the stimulation with 
both IL-2 and IL-4 as compared with the effect of IL-2 
alone. The IL-4 responsive cells seemed tobe a subset 
of the IL-2 responsive cells. 15 In view of the recently 
demonstrated potency of IL-7 and IL-9 on T cell 
growth, we investigated the cell kinetics of activated T 
cells stimulated with IL-7 and IL-9 and a putative 
synergism of these lyrnphokines with IL-4. Apart 
from the [3H]thymidine proliferation assay we applied 
the bivariate BrdU/Hoechst technique for the examin-
ation ofT cell proliferation. This method is based on 
incorporation of 5-bromo-2' -deoxyurdine (BrdU) into 
the DNA of proliferating cells. The quenching of 
Hoechst 33258 dye (Hoechst) fluorescence allows to 
separate cells according to the number of cell cycles 
( CC) the cells traversed during the observed time 
period. The unique attribute of this methodisthat it 
provides a clear distinction between different CC 
compartments of at least three consecutive CCs. 
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RESULTS 
The lymphokine-induced proliferation of the 
PHA-activated T cells was measured by means of 
eHJthymidine incorporation (Figs 1 and 2). Without 
0 
0 250 0 
~ 
.....-
X ....... r-- r--
Q) 200 
IT ~ 1 .., Z: ....-::s 1::: 150 ....... 
!!!! !!!! I! II 
·s ::-=: 
~ 100~~ 
'II.: 0 Q) 0. rn 50 L ~ ::s 0 :::: 0 0 A B c D E F G 
Figure 1. eHJthymidioe fncorporation in T ceJis PHA activated for 
3 days. 
T cells are activated for 3 days with PHA and then stimulated with 
(A) IL-4, (B) Ilr7, (C) IL-9, (D) IL-4 and IL-7, (E) IL-4 and JL-9, 
(F) IL-7 and IL-9, (G) IL-·4, IL-7 and IL-9 for 24 (•) or 72 h (0). 
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Figure 2. [3H]thymidine incorporation in T cells PHA activated for 
7 days. 
T cells are activated for 7 days with PHA and then stimulated with 
(A) IL-4, (B) IL-7, (C) IL-9, (D) IL-4 and IL-7, (E) IL-4 and IL-9, 
(F) IL-7 and IL-9, (G) IL-4, IL-7 and IL-9 for 24 C•) or 72 h (0). 
the addition of any lymphokine, PHA-activated T 
cells showed only a negligible [3H]thymidine incor-
poration, whereas with IL-9 a weak, but consistent 
proliferative effect on T cells activated with PHA for 3 
days was seen. In contrast, both IL-4 and IL-7 bad a 
strong proliferative effect on T cells activated with 
PHA for either 3 or 7 days. T cells preactivated for 3 
days showed a higher eHJthymidine uptake when 
stimulated with IL-7 than with IL-4. The addition of 
IL-4, respectively IL-9, to IL-7 had neither significant 
synergistic nor inhibitory effects. In contrast, IL-4 was 
the most potent factor for the proliferation of T cells 
preactivated for 7 days with PHA and the addition of 
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IL-7, respectively IL-9, to IL-4 did not influence the 
proliferating effect compared to IL-4 alone. 
Preliminary data have shown that the detection of 
both [3H]thymidine and the noil-radioactive thymi-
dine analogue BrdU incorporated in proliferating 
cells gave comparable results (data not shown). To 
clarify further the role of the different cytokines and 
their various combinations in their capacity to drive 
;;eJis through different compartments of cell cycles, 
the proliferative response of activated T cells could be 
examined in more detail using a metbad labeHing the 
cells continuously with bromodeoxyuridine in combi-







IL-4 + IL-7 
G2' G2 
Gl" s: ,t~;,:., 
, fl~~::·.. G 1, GOiG 1 
•ilh=.· 
IL-7 + IL-9 IL-4 + IL-7 + IL-9 
G2'. .G2 
S" ::.: .. , ... . .:·:~::)~~:l, ß 
·f". G/~,>;·~'! 
BrdU/Hoechst fluorescence 
Figure 3. Bivariate Hoechst/etWdium bromide cytogram of PHA 
activated cell cultures contiouously Iabelied with 100 JJ.M BrdU in 
the presence of the indicated interleukins. 
The abscissa displays BrdU-quenched Hoechst ftuorescence while 
the ordinate shows unquenched ethidium bromide fluorescence. 
Nomenclature of the three CC displayed is GO/G 1, S, G2; G 1', S', 
G2'; Gl", S"; where the prime denotes the number of rounds of 
replication in the presence of BrdU. 
Figure 3 shows representative cytograms of cul-
tures preactivated for 3 days and then exposed to the 
different lymphokines for 72 h. The abscissa rep-
resents Hoechst fluorescence, which is quenched if 
BrdU is incorporated during S phase traverse of cells, 
whereas the ordinate shows BrdU-insensitive ethi-
dium bromide fluorescence. Each dot represents an 
individual cell; dusters arise where cells with similar 
fluorescence concur. In the untreated control, nearly 
all cells remained in the resting state ( GO/G 1). In 
contrast, the cytogram of the IL-4 treated culture 
exhibits many cells left from the GO/G1 duster (G1 1 ). 
These cells have undergone one round of BrdU incor-
poration during S phase and halved their DNA con-
tent aftertraverse of the G2 compartment of the cell 
cycle. The trail moving to the right side and up from 
the G 11 duster represents cells passing through a sec-
ond S phase (S 1) and a second G2 phase (G2') in the 
second cell cyde. Due to the bilifary BrdU substitu-
tion, this trail no Ionger moves to the left, but still 
some additional quenching of Hoechst fluorescence is 
afforded during the second cycle S phase. Cells under-
gone a second mitosis appear to the left of the G 11 
duster (G1"). A few signals representing cells in the S 
phase ofthe third cycle can also be detected (S"). The 
panel representing the IL-7 treated culture elicits an 
even stronger proliferative response, whereas the IL-9 
treated cells show little, but significant proliferation. 
Combinations of the interlenkins including IL-7 Iead 
to cytograms similar to that of IL-7 alone, whereas the 
combination of IL-4 and IL-9 Ieads to a similar cyto-
gram to that of IL-4 alone. 
Quantification of the data are shown in Tables 1 
and 2. The data are corrected for the nurober of cell 
divisions a given cell has undergone and for the back-
ground. Most T cells activated for 3 days and then 
stimulated with the different lymphokines for 24 h 
remained in the GO/G 1 phase of the first CC. When 
activated for 3 days and then stimulated for 72 h with 
the lymphokines, more than 35% of the cells stimu-
lated with IL·7 alone or with a combination of lym-
phokines including IL-7 have left the first CC. In con-
trast, about 20% of the cells stimulated with IL-4 
alone are found in the second or third CC. When 
stimulated for 24 h with IL-9 alone, about 1% of the 3 
day PHA-blasts responded with a progression through 
cell cycles. The combination of IL-9 with IL-4, 
respectively IL-7, does not significantly influence the 
distribution of cells stimulated with IL-4, respectively 
IL-7, alone. 
When activated with PHA for 7 days and then 
stimulated for 24 h with IL-4 alone or with a combi-
nation of Jymphokines including IL-4, 20% of the cells 
have left GO/G 1 of the first CC. IL-7 alone or the 
combination of IL-7 and IL-9 showed a weaker stimu-
latory effect than those achieved by IL-4 alone and 
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TABLE 1. Cell cycle distribution of T ceUs, activated with 
PHA for 3 days and then stimulated with tbe indicated 
interleukins for 24, 48 or 72 h. 
First CC Second CC Third CC 
GO/Gl s G2 GO/GI s G2 GO/Gl s G2 
24 h 
Control 100 0 0 0 0 0 0 0 0 
4 94.2 3.6 0 2.2 0 0 0 0 0 
7 88.9 7.5 0 3.6 0 0 0 0 0 
9 98.9 1.1 0 0 0 0 0 0 0 
4+7 84.2 9.2 1.3 5.3 0 0 0 0 0 
4+9 95.2 4.8 0 0 0 0 0 0 0 
7+9 88.6 7.9 0 3.5 0 0 0 0 0 
4+7+9 88.8 6.5 0.5 4.2 0 0 0 0 0 
48 h 
Control 100 0 0 0 0 0 0 0 0 
4 77.5 3.2 0 4.4 7.2 1.2 6.5 0 0 
7 60.8 4.7 2.0 9.3 11.3 2.6 9.3 0 0 
9 96.6 0 0.9 0.8 0.4 1 0.3 0 0 
4+7 62.5 3.4 1.1 3.9 12.9 3.7 12.5 0 0 
4+9 76.3 3.2 0 6.4 7.4 1.4 5.3 0 0 
7+9 64.4 5.4 1.9 8 9.9 2.8 7.6 0 0 
4+7+9 64.3 3.9 1.5 3.2 13.2 2.9 11.0 0 0 
72h 
Control 100 0 0 0 0 0 0 0 0 
4 78.4 2.4 1.1 6.4 3.2 1.7 6.8 0 0 
7 56.1 4.1 3 12.3 7.3 3.8 13.4 0 0 
9 96.4 0.4 0 2.8 0 0 0.4 0 0 
4+7 59.6 3.4 1.7 6.1 6.7 4.8 17.7 0 0 
4+9 72.5 1.6 1.1 7.1 4.2 2.2 11.3 0 0 
7+9 58.4 4.3 1.7 10 5.5 4.9 13.7 1.5 0 
4+7+9 57.2 3.2 1.2 10.5 5.7 4.7 14.7 2.8 0 
combinations including IL-4. When stimulated for 72 
h with IL-4 alone and combinations including IL-4, 
only about 45% of the cells remained in GO/G1 of the 
first CC. In contrast, about 65% of the T cells stimu-
lated for 72 h with IL-7 alone, or with IL-7 and IL-9 
were found in GO/G 1 of the first CC. Stimulated with 
IL-9 alone, only a small percentage of the 7 day PHA-
blasts were driven into the second, but not into the 
third CC. 
DISCUSSION 
The stimulatory effects of different lymphokines 
on activation and proliferation ofT cells can be exam-
ined with unprecedented precision by the bivariate 
BrdU/Hoechst technique. By this technique it is poss-
ible to obtain the distribution of stimulated cells in 
different CC compartments in at least three different 
CC. l6-IS In our test system, IL-4 as IL-7 and IL-9 
drives activated T cells through more than one CC. So 
far, IL-9 was shown to stimulate proliferation of some 
murine Helper T cell clones. No direct response of 
human T cells to IL-9 was observed, moreover it 
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TABLE2. Cell cycle distribution ofT cells, activated with 
PHA for 7 days and then stimulated with the indicated 
interlenkins for 24, 48 or 72 h. 
First CC Secend CC Third CC 
G0/01 s G2 00/01 s 02 GO/Gl s 02 
24 h 
Contra! 100 0 0 0 0 0 0 0 0 
4 82.5 3.4 9.1 5 0 0 0 0 0 
7 95.4 0 1.3 3.3 0 0 0 0 0 
9 100 0 0 0 0 0 0 0 0 
4+7 83.7 0 11.5 4.8 0 0 0 0 0 
4+9 75.2 9.1 9.7 6 0 0 0 0 0 
7+9 95 0.5 3.4 1.1 0 0 0 0 0 
4+7+9 75 10 9.4 5.6 0 0 0 0 0 
48 h 
Control 100 0 0 0 0 0 0 0 0 
4 53.4 2 0.9 11 15.4 2.9 14.4 0 0 
7 77.8 2.3 1.8 11.9 4.3 0.4 1.5 0 0 
9 91.5 3.4 2.9 1.1 1.0 0.2 0 0 0 
4+7 51.7 1.6 0.6 8.6 16.2 2.6 18.7 0 0 
4+9 55.9 1.6 0.1 8.3 13.7 2.7 17.7 0 0 
7+9 75.3 3.5 1.2 15.2 4.3 0.5 0 0 0 
4+7+9 58.9 5 0.8 12.7 14.5 1.5 6.6 0 0 
72h 
Control 100 0 0 0 0 0 0 0 0 
4 44.8 0 2 7.5 9.9 1.2 34.6 0 0 
7 62.5 1.6 2.6 24 3.6 0.6 5.1 0 0 
9 88.6 0 1.1 8.7 1.2 0.4 0 0 0 
4+7 45.9 0.1 2 8.5 6.6 2.4 34.5 0 0 
4+9 43.8 0 2.3 10.8 10.2 0.9 32 0 0 
7+9 62.7 0 3 20.1 4.4 0.2 9.6 0 0 
4+7+9 48.1 0 3 9.3 7.1 1.6 30.9 0 0 
seemed that human T cells need strong and prolonged 
activation for proliferation (Houssiau et al., submitted 
for publication). We conclude that in our test system 
only a small proportion of cells was able to proliferate 
in response to IL-9. Interestingly, the proliferation 
was highest for T cells activated for 3 days and stimu-
lated with IL-9 for 24 h. It remains obscure and will be 
addressed in future experiments whether the prolifer-
ating cells are T cells with special features or func-
tions. Although IL-9 might be a T cell growth factor 
for some distinct T cell clones, it remains unclear what 
kind of preactivation the cells have bad and what kind 
of additional signals will be needed for their prolifer-
ation. However, it seems to be clear that IL-9 will be 
no cofactor for the major known T cell growth factors 
including IL-2, IL-4 and IL-7 ( data for IL-2 not 
shown). 
Independent of the activation period (3 and 7 
days), the percentage of the IL-7 responders stimu-
Iated to leave GO/G 1 of the first CC remains constant 
with about 35% of the cells. These data are concor-
dant with the findings of Welch showing that about 
30% of IL-7 induced T cells entered into the S phase 
on day 3.7 In contrast, the percentage of IL-4 re-
sponders increased from 30% to over 50% of the T 
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cells activated for 3 and 7 days, respectively. Further-
more, neither synergistic nor inhibitory effects of IL-4 
and IL-7 were seenon Tcells activated for 3 or 7 days. 
Thus, one is tempted to conclude that in the system 
with 3 days activated T cells, the population of IL-4 
responsive cells is at least an overlapping, if notareal 
subset of the population of the IL-7 responsive cells, 
whereas in the systern with 7 days activated T cells, all 
or rnost IL-7 responders arealso IL-4 responders, but 
only some IL-4 responders are IL-7 responders. Com-
patible to our data, Okazaki and Masuda19•20 did not 
find synergistic or inhibitory effects of these lympho-
kines, whereas Bertagnolli21 described an additive 
effect of IL-4 and IL-7 on rnurine thymocytes preacti-
vated with ConA for 48 h. These differences may be 
due to the different steps of differentiation. Concord-
ant to our results, Armitage14 reported a stronger pro-
liferative effect of IL-7 than of IL-4 on human T cells. 
In cantrast to IL-4, IL-7 was shown to act on mature T 
cells in the absence of a comitogen13 and it was found 
that freshly isolated T cells already express high levels 
of IL-7r while they express low Ievels of IL-4r.22 Acti-
vation with PHA induces the expression of the IL-4r 
but has Iittle or even negative effects on the Ievel of 
the IL-7r expression.22 These Observations suggest 
that putative different activation states of T cells acti-
vated for 3 and 7 days, respectively, rnay be respon-
sible for the discordant findings of proliferative re-
sponses to IL-4 and IL-7. 
The bivariate BrdU/Hoechst technique is an im-
portant tool to uncover the interaction between differ-
ent interleukins. Further investigations have to char-
acterize the responsive cells for each factor to fully 
understand the mechanisrns regulating T cell prolifer-
ation. 
MATERIALS AND METHODS 
I nterleukins 
The recombinant IL-4 proteinwas produced in Escheri-
chia coli by the expression of the IL-4 cDNA.24 T cells, 
activated with PHA for 7 days and then incubated with IL-4 
for 72 h, were used to determine the biological activity of 
IL-4 using [3H]thymidine incorporation (modified according 
to Yokota et a/.)1 Purified riL-4 had a specific activity of 1.2 
x 106 U/mg. 
Recombinant human IL-7 was produced in Escherichia 
coli by the expression of the IL-7 cDNA.24 The recombinant 
material is equivalent to that of the natural IL-7 except for 
the presence of an N-terminal methionine. The protein has 
a molecular weight of approximately 17.5 kDa. Peripheral 
blood lymphocytes, activated with PHA for 72 h, were used 
to determine the biologic activity (1 x 107 U/mg) in a 
[3H]thymidine incorporation assay. 
Recombinant human IL-9 (specific activity 6.6 x 106 U/ 
rng in the M07E cell test10 was a kind gift of Dr J aques van 
Snick {Ludwig Institute for Cancer Research, Bruxelles, 
Belgium). 
Preparation of PHA Activated T Cells 
Peripheral blood mononuclear cells (PBMC) 
from normal individuals were separated by Ficoll-
Hypaque density gradient centrifugation. PBMC 
were cultured in RPMI-1640 medium ( Gibco, Grand 
Island, NY) with 10% fetal calf serum (FCS, Gibco) 
(1 x 107 cells/ml) in the presence of 5 J.Lg/ml 
phytohemagglutinin HA-15 (Wellcome, Research 
Triangle Park, NY) in a humid atmosphere wiht 5% 
C02 at 37°C for 3 and 7 days. 
[3H]thymidine Incorporation Assay 
The PHA activated T cells were extensively 
washed, then 5 x 104 cells were placed in a 96-well flat 
bottom plate and cultured in 200 J.Ll of RPMI-1640 
containing 10% FCS in the presence of the different 
recombinant lymphokines. The culture was then 
pulsed with 0.5 J.LCi eHJthymidine (Amersham 
Corp., Arlington Heights, IL) for the last 6 h and then 
harvested onto glass fibre filters (Scatron, Oslo, Nor~ 
way). The radioactivity was counted by liquid scintil-
lation. All data are indicated as the mean counts per 
minute of at least triplicate cultures. 
Bromodeoxyuridine Labelling 
PHA-activated T cells were exposed to the inter-
leukins as described above and concomitantly the cul-
ture medium was supplemented with 100 J.LM of 
bromodeoxyuridine (BrdU) and deoxycytidine. All 
culture plates were carefully wrapped in aluminium 
foil to avoid exposure to light of short wavelengths. 
After 24, 4.8 or 72 h of culture, cells were harvested 
under illumination with red light only. Until analysis, 
cells were stored in the dark at - 20°C in culture 
medium supplement with 10% FCS and 10% di~ 
methylsulphoxide. 
Cell-staining and Flow Cytometry 
After thawing, cell pellets were resuspended in a 
staining buffer containing 1.2 J.Lg of Hoechst 33258 
and 2.0 J.Lg of ethidium bromide per ml of buffer. 17•18 
Flow cytometric analysis was performed with an epi-
illumination system of conventional design (ICP 22, 
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Ortho Diagnostic Systems, Raritan, NJ) equipped 
with a mercury arc lamp (HBO 100, Osram, Berlin, 
FRG). Bivariate cytograms of Hoechst and ethidium 
bromide fiuorescence were digitalized and recorded 
with a PDP 11123 microcomputer (Digital Equipment 
Corporation, Maynard, MA). Cells belanging to 
three successive cell cycles can be distinguished due to 
BrdU quenching of Hoechst fluorescence. 16- 18 By 
electronic selection of the signal clusters representing 
each cell cycle, rotation and deconvolution, conven-
tional cell cycle distributions were obtained, which 
were fitted with a standard cell cycle algorithm 
(Phoenix Flow System, San Diego, CA). The cell 
numbers in each cell cycle were normalized to the 
percentage of original cells by correcting for the 
numbers of cell divisions by which cells originated. 
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